Ayesha Gulzar, PharmD

All articles by Ayesha Gulzar, PharmD

Liver Health

Investigational Treatment ARO-AAT Improves Liver Health in AATD

Interim results from a study on the investigational treatment ARO-AAT showed improvements in multiple measures of liver health, including fibrosis, with a reduction in intrahepatic Z-AAT burden. ARO-AAT is being developed as a treatment for the rare genetic liver disease linked with alpha-1 antitrypsin deficiency (AATD).  “The results represent an important breakthrough for the field…


Inhaled Treprostinil Solution Improves FVC in Patients With IPF

Inhaled treprostinil (Tyvaso®) was associated with improved forced vital capacity (FVC), compared to placebo, over 16 weeks in patients with idiopathic pulmonary fibrosis (IPF), a post-hoc analysis found. “We measured FVC in the INCREASE study as a safety endpoint to make sure treatment with Tyvaso was not exacerbating patients’ underlying lung diseases, said Leigh Peterson,…

Next post in News Briefs